glp 1 and alzheimer's disease glp1 #diabetes #sglt2 #dementia #alzheimer | Robert Gabbay MD, PhD GLP-1R agonists protect against Alzheimer's

structural activity relationship

2023 Apr 21;15(8):2009

Ipamorelin: 100-300 mcg per injection CJC-1295 (no DAC / mod GRF 1-29): 100-300 mcg per injection Frequency: 1-3 injections daily, subcutaneous, ideally on an empty stomach or 90 minutes after the last meal and before sleep Cycle length: 12-24 weeks followed by a 4-to-8-week break to avoid GH receptor downregulation Injection site: Abdomen, approximately 1-2 inches from the navel, rotating sites each injection The pre-sleep injection is prioritized because it coincides with the largest endogenous GH pulse, which occurs roughly 60-90 minutes after sleep onset and is tied to slow-wave sleep [8]

Popov, A

SUGGESTED USE: As a dietary supplement

Treatment begins with identifying and reducing ongoing exposure while restoring the bodys regulatory stability